Cevimeline Pregnancy and Breastfeeding Warnings
Brand names: Evoxac
Medically reviewed by Drugs.com. Last updated on Jul 26, 2024.
Cevimeline Pregnancy Warnings
This drug should be used during pregnancy only if the benefit outweighs the risk.
US FDA pregnancy category: C
Animal studies have revealed evidence of a reduction in the mean number of implantations. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
Cevimeline Breastfeeding Warnings
A decision should be made to discontinue breastfeeding or discontinue the drug, taking into account the importance of the drug to the mother.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: The effects in the nursing infant are unknown.
.
See also
References for pregnancy information
- (2001) "Product Information. Evoxac (cevimeline)." Daiichi Pharmaceuticals
References for breastfeeding information
- (2001) "Product Information. Evoxac (cevimeline)." Daiichi Pharmaceuticals
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.